Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: A randomized double-blind, placebo-controlled trial

Journal of Bone and Mineral Research

Volumn 24, Issue 7, 2009, Pages 1335-1344

  Fahrleitner Pammer, Astrid ^a   Piswanger Soelkner, Jutta Claudia ^a   Pieber, Thomas Rudolf ^a   Obermayer Pietsch, Barbara Maria ^a   Pilz, Stefan ^a   Dimai, Hans Peter ^a   Prenner, Guenther ^a   Tscheliessnigg, Karl Heinz ^a   Hauge, Ellen ^b   Portugaller, Rupert Horst ^a   Dobnig, Harald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bone biopsy; Cardiac transplantation; Histomorphometry; Ibandronate; Immunosuppressive therapy; Osteoprotegerin; Vertebral fracture

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; COLLAGEN TYPE 1; CYCLOSPORIN A; IBANDRONIC ACID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSTEOCALCIN; PLACEBO; PREDNISOLONE; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMUR NECK; GRAFT RECIPIENT; GRAFT REJECTION; HEART GRAFT; HUMAN; LUMBAR SPINE; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SAMPLE SIZE; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

ACID PHOSPHATASE; ADULT; ANTACIDS; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CALCIUM CARBONATE; CHOLECALCIFEROL; COLLAGEN TYPE I; DIPHOSPHONATES; DOUBLE-BLIND METHOD; HEART TRANSPLANTATION; HUMANS; ISOENZYMES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SPINAL FRACTURES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349125053     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090216     Document Type: Article

References (47)

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ 2000 The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report-2000. J Heart Lung Transplant 19:909-931.
2. Fahrleitner A, Prenner G, Leb G, Tscheliessnigg KH, Piswanger-Solkner C, Obermayer-Pietsch B, Portugaller HR, Berghold A, Dobnig H 2003 Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. Bone 32:96-106. (Pubitemid 36173817)
3. Dobnig H 2004 Show a heart for bones in time - fractures remain a common problem following cardiac transplantation. Wien Klin Wochenschr 116:151-154. (Pubitemid 38480321)
4. Lindsay R 2004 Bone loss after cardiac transplantation. N Engl J Med 350:751-754.
5. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C, Otto G, Lange R. Theilmann L, Zimmerman R, Pritsch M, Ziegler R 2001 Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow-up study. Lancet 357:342-347. (Pubitemid 32128540)
6. Sambrook PN, Kelly PJ, Fontana D, Nguyen T, Keogh A, Macdonald P, Spratt P, Freund J, Eisman JA 1994 Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos Int 4:273-276. (Pubitemid 24291435)
7. Shane E, Rivas M, McMahon DJ, Staron RB, Silverberg SJ, Seibel MJ, Mancini D, Michler RE, Aaronson K, Addesso V, Lo SH 1997 Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab 82:1497-1506. (Pubitemid 27200425)
8. Van Cleemput J, Daenen W, Nijs J, Geusens P, Dequeker J, Vanhaecke J 1995 Timing and quantification of bone loss in cardiac transplant recipients. Transpl Int 8:196-200.
9. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P 1996 Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 26:549-555. (Pubitemid 26291904)
10. Cohen A, Sambrook P, Shane E 2004 Management of bone loss after organ transplantation. J Bone Miner Res 19:1919-1932. (Pubitemid 41103406)
11. Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, Mancini D, Addesso V, Michler RE, Factor-Litvak P, 1996 Fracture after cardiac transplantation: A prospective longitudinal study. J Clin Endocrinol Metab 81:1740-1746. (Pubitemid 26152456)
12. Ippoliti G, Pellegrini C, Campana C, Rinaldi M, D'Armini A, Goggi C, Aiello M, Vigano M 2003 Clodronate treatment of established bone loss in cardiac recipients: A randomized study. Transplantation 75:330-334. (Pubitemid 36222957)
13. Henderson K, Eisman J, Keogh A, MacDonald P, Glanville A, Spratt P, Sambrook P 2001 Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 16:565-571. (Pubitemid 32173372)
14. Sambrook P, Henderson NK, Keogh A, MacDonald P, Glanville A, Spratt P, Bergin P, Ebeling P, Eisman J 2000 Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 15:1818-1824. (Pubitemid 30666235)
15. Stempfle HU, Werner C, Echtler S, Wehr U, Rabeck WA, Siebert U, Ubefuhr P, Angermann CE, Theisen K, Gartner R 1999 Prevention of osteoporosis after cardiac transplantation: A prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 68:523-530. (Pubitemid 29416628)
16. Krieg MA, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiebaud D, Burckhardt P 2001 Intravenous pamidronate as treatment for osteoporosis after heart transplantation: A prospective study. Osteoporos Int 12:112-116. (Pubitemid 32244663)
17. Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D 2004 Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med 350:767-776. (Pubitemid 38209646)
18. Shane E, Rodino MA, McMahon DJ, Addesso V, Staron RB, Seibel MJ, Mancini D, Michler RE, Lo SH 1998 Prevention of bone loss after heart transplantation with antiresorptive therapy: A pilot study. J Heart Lung Transplant 17:1089-1096. (Pubitemid 28547277)
19. Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F 1997 Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 60:155-159. (Pubitemid 27057499)
20. Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C 2000 Prevention of osteoporosis in heart transplant recipients: A comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 67:116-121. (Pubitemid 30616007)
21. Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B, Reginster JY, Recker RR, Hughes C, Lewiecki EM, Felsenberg D, Delmas PD, Kendler DL, Bolognese MA, Mairon N, Cooper C 2005 Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 20:1315-1322.
22. Recker RR, Gallagher R, MacCosbe PE 2005 Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856-861. (Pubitemid 40911458)
23. Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G 2003 Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Osteoporos Int 14:82-89. (Pubitemid 36267905)
24. Leu CT, Luegmayr E, Freedman LP, Rodan GA, Reszka AA 2006 Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy. Bone 38:628-636.
25. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, Dobbels F, Rahmel AO, Keck BM, Hertz MI 2007 Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26:769-781. (Pubitemid 47199081)
26. Genant HK, Wu CY, van Kuijk C, Nevitt MC 1993 Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148. (Pubitemid 23261108)
27. Black DM, Palermo L, Nevitt MC, Genant HK, Christensen L, Cummings SR 1999 Defining incident vertebral deformity: A prospective comparison of several approaches. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 14:90-101.
28. Genant HK, Siris E, Crans GG, Desaiah D, Krege JH 2005 Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index. Bone 37:170-174. (Pubitemid 40962423)
29. Fahrleitner A, Prenner G. Kniepeiss D, Iberer F, Tscheliessnigg KH, Piswanger-Solkner C, Obermayer-Pietsch B, Leb G, Dobnig H 2002 Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. Wien Klin Wochenschr 114:717-724. (Pubitemid 35033595)
30. Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G, Mayr A, Jocher J, Xu Q, Pietschmann P, Teitelbaum S, Smolen J, Willeit J 2004 Soluble RANKL and risk of non-traumatic fracture. JAMA 291:1108-1113. (Pubitemid 38541688)
31. Meunier PJ, Chavassieux P 1985 [Histomorphometry. Method for evaluating the bone mass.] Rev Rhum Mal Osteoartic 52:669-673.
32. Reeve J, Arlot ME, Chavassieux PM, Edouard C, Green JR, Hesp R, Tellez M, Meunier PJ 1987 The assessment of bone formation and bone resorption in osteoporosis: A comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics. J Bone Miner Res 2:479-489.
33. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
34. Kragstrup J, Gundersen HJ, Melsen F, Mosekilde L 1982 Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Relat Res 4:113-119.
35. Eriksen EF, Melsen F, Mosekilde L 1984 Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res 5:235-242. (Pubitemid 14069657)
36. Steiniche T, Eriksen EF, Kudsk H, Mosekilde L, Melsen F 1992 Reconstruction of the formative site in trabecular bone by a new, quick, and easy method. Bone 13:147-152.
37. Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH 2008 Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 23:1850-1858.
38. Berguer DG, Krieg MA, Thiebaud D, Burckhardt P, Stumpe F, Hurni M, Sadeghi H, Kappenberger L, Goy JJ 1994 Osteoporosis in heart transplant recipients: A longitudinal study. Transplant Proc 26:2649-2651. (Pubitemid 24329265)
39. Valimaki MJ, Kinnunen K, Tahtela R, Loyttyniemi E, Laitinen K, Makela P, Keto P, Nieminen M 1999 A prospective study of bone loss and turnover after cardiac transplantation: Effect of calcium supplementation with or without calcitonin. Osteoporos Int 10:128-136. (Pubitemid 29462201)
40. Epstein S, Inzerillo AM, Caminis J, Zaidi M 2003 Disorders associated with acute rapid and severe bone loss. J Bone Miner Res 18:2083-2094. (Pubitemid 37463302)
41. Shane E, Rivas MC, Silverberg SJ, Kim TS, Staron RB, Bilezikian JP 1993 Osteoporosis after cardiac transplantation. Am J Med 94:257-264.
42. Sasaki N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y 2005 Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 23:41-47.
43. Sivagurunathan S, Muir MM, Brennan TC, Seale JP, Mason RS 2005 Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res 20:390-398. (Pubitemid 40293487)
44. Hofle G, Tautermann G, Saely CH, Drexel H 2004 Sex-hormone-binding globulin is negatively correlated with femoral bone-mineral density in male cardiac-transplant recipients. Wien Klin Wochenschr 116:170-175. (Pubitemid 38480324)
45. Fleischer J, McMahon DJ, Hembree W, Addesso V, Longcope C, Shane E 2008 Serum testosterone levels after cardiac transplantation. Transplantation 85:834-839.
46. Boncimino K, McMahon DJ, Addesso V, Bilezikian JP, Shane E 1999 Magnesium deficiency and bone loss after cardiac transplantation. J Bone Miner Res 14:295-303. (Pubitemid 29066256)
47. Glendenning P, Kent GN, Adler BD, Matz L, Watson I, O'Driscoll GJ, Hurley DM 1999 High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry. Clin Endocrinol (Oxf) 50:347-355. (Pubitemid 29166715)